<DOC>
	<DOC>NCT00157872</DOC>
	<brief_summary>A study to compare rofecoxib versus naproxen in the treatment of Chinese patients with rheumatoid arthritis.</brief_summary>
	<brief_title>A Study of Rofecoxib Versus Naproxen in the Treatment of Chinese Patient With Rheumatoid Arthritis (0966-231)</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<mesh_term>Rofecoxib</mesh_term>
	<criteria>Chinese males or females at least 18 years of age with rheumatoid arthritis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>